title: [Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolution].
authors.affiliation: Institut de cancérologie, hospices civils de Lyon, 165, chemin du Grand-Revoyet, 69310 Pierre-Bénite, France. Electronic address: gilles-freyer@univ-lyon1.fr.
authors.forename: Gilles
authors.initials: G
authors.lastname: Freyer
authors.affiliation: Société française du cancer, hôpital Saint-Louis, 1, avenue Claude-Vellefaux, 75474 Paris cedex 10, France. Electronic address: pr.m.marty@gmail.fr.
authors.forename: Michel
authors.initials: M
authors.lastname: Marty
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
authors.forename: Bruno
authors.initials: B
authors.lastname: Chauffert
authors.forename: Gérard
authors.initials: G
authors.lastname: Ganem
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Lotz
authors.forename: Frédéric
authors.initials: F
authors.lastname: Marchal
authors.forename: Jacques
authors.initials: J
authors.lastname: Medioni
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ray-Coquard
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002017:Budgets; D004469:Economics, Hospital; D005572:Formularies, Hospital as Topic; D006801:Humans
chemical_list: D000970:Antineoplastic Agents